Pembrolizumab plus chemotherapy in Japanese patients with metastatic squamous non‐small<scp>‐</scp>cell lung cancer in KEYNOTE‐407Shunichi Sugawara, Terufumi Kato, Tomonori Hirashima et al.|Cancer Science|2023Cited by 16
Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Small Cell Lung Cancer CohortMakoto Nishio, Koichi Azuma, Shuji Murakami et al.|Cancer Research Communications|2024Cited by 4
Longitudinal recurrence risk of adjuvant cytotoxic chemotherapy and gefitnib in resected lung cancer: A combined analysis of phase III studiesHiroaki Akamatsu, Tetsuya Mitsudomi, Tomomi Nishikawa et al.|Lung Cancer|2025Cited by 2